{
    "title": "Woodford-backed Prothena targeted by short seller Kerrisdale",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5062441/Woodford-backed-Prothena-targeted-short-seller-Kerrisdale.html",
    "date": "2017-11-08",
    "keywords": [
        "kerrisdale",
        "prothena",
        "woodford",
        "fund",
        "drug",
        "share",
        "price",
        "percent",
        "alasdair",
        "pal",
        "ben",
        "hirschler",
        "capital",
        "position",
        "drugmaker",
        "company",
        "biotech",
        "antibody",
        "amyloidosis",
        "adrangi",
        "spokesperson",
        "investment",
        "stock",
        "product",
        "neod001",
        "protein",
        "trial",
        "year",
        "phase",
        "investor",
        "blowup",
        "asset",
        "disease",
        "effectiveness",
        "conclusion",
        "work",
        "founder",
        "sahm",
        "time",
        "aim",
        "holding",
        "trust",
        "earlystage",
        "meaning",
        "incubator",
        "report",
        "march",
        "plug",
        "number",
        "side",
        "trade",
        "elan",
        "condition",
        "buildup",
        "amyloid",
        "tissue",
        "function",
        "heart",
        "kidney",
        "failure",
        "cure",
        "example",
        "chemotherapy",
        "result",
        "need",
        "designation",
        "food",
        "administration",
        "agency",
        "industry",
        "iib",
        "iii",
        "earlierstage",
        "study",
        "analysis",
        "problem",
        "flagship",
        "equity",
        "income",
        "kind",
        "september",
        "video",
        "reporting",
        "editing",
        "fenton"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}